Abbott Receives FDA Approval for a Once-daily Kaletra-based (lopinavir/ritonavir) Treatment Regimen
home > MSN news
Food and Drug Administration (FDA) approval to market a once-daily dosing regimen for Kaletra (lopinavir/ritonavir), a protease inhibitor used in combination with other anti-HIV medications, for the initial treatment of HIV. ... FDA APPROVAL FOR A ONCE-DAILY KALETRA-BASED (LOPINAVIR/RITONAVIR) TREATMENT REGIMEN -NEW ...
- link to Abbott Receives FDA Approval for a Once-daily Kaletra-based (lopinavir/ritonavir) Treatment Regimen -
Last update: 05/26/2005